Overcoming barriers by local drug delivery with liposomes

SG Antimisiaris, A Marazioti, M Kannavou… - Advanced drug delivery …, 2021 - Elsevier
Localized or topical administration of drugs may be considered as a potential approach for
overcoming the problems caused by the various biological barriers encountered in drug …

[HTML][HTML] Nanoparticle vaccines against infectious diseases

R Pati, M Shevtsov, A Sonawane - Frontiers in immunology, 2018 - frontiersin.org
Due to emergence of new variants of pathogenic micro-organisms the treatment and
immunization of infectious diseases have become a great challenge in the past few years. In …

Nanoparticle-based local antimicrobial drug delivery

W Gao, Y Chen, Y Zhang, Q Zhang, L Zhang - Advanced drug delivery …, 2018 - Elsevier
Despite the wide success of antibiotics in modern medicine, the treatment of bacterial
infections still faces critical challenges, especially due to the rapid emergence of antibiotic …

Lipid-based nanovesicles for nanomedicine

N Grimaldi, F Andrade, N Segovia… - Chemical society …, 2016 - pubs.rsc.org
Molecular self-assembly has enabled the fabrication of biologically inspired, advanced
nanostructures as lipid-based nanovesicles (L-NVs). The oldest L-NVs, liposomes, have …

Recent advances with liposomes as pharmaceutical carriers

VP Torchilin - Nature reviews Drug discovery, 2005 - nature.com
Liposomes—microscopic phospholipid bubbles with a bilayered membrane structure—have
received a lot of attention during the past 30 years as pharmaceutical carriers of great …

Nanoparticle approaches against bacterial infections

W Gao, S Thamphiwatana… - Wiley interdisciplinary …, 2014 - Wiley Online Library
Despite the wide success of antibiotics, the treatment of bacterial infections still faces
significant challenges, particularly the emergence of antibiotic resistance. As a result …

Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections

N Abed, P Couvreur - International journal of antimicrobial agents, 2014 - Elsevier
In the field of antibiotherapy, intracellular infections remain difficult to eradicate mainly due to
the poor intracellular penetration of most of the commonly used antibiotics. Bacteria have …

Nanosuspensions in drug delivery

BE Rabinow - Nature reviews Drug discovery, 2004 - nature.com
A surprisingly large proportion of new drug candidates emerging from drug discovery
programmes are water insoluble, and therefore poorly bioavailable, leading to abandoned …

Nanomedicine in pulmonary delivery

HM Mansour, YS Rhee, X Wu - International journal of …, 2009 - Taylor & Francis
The lung is an attractive target for drug delivery due to noninvasive administration via
inhalation aerosols, avoidance of first-pass metabolism, direct delivery to the site of action …

Nano-therapeutics: a revolution in infection control in post antibiotic era

S Zaidi, L Misba, AU Khan - Nanomedicine: Nanotechnology, Biology and …, 2017 - Elsevier
With the arrival of antibiotics 70 years ago, meant a paradigm shift in overcoming infectious
diseases. For decades, drugs have been used to treat different infections. However, with …